The Rule Of Doubling Your Money: How It Works

forbestheatreartsoxford.com
Otonomy, Inc. (OTIC) was a big mover last session, as the company saw its shares rise almost 9% on the day. The share price gain came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 13.5% since Jun 10, 2015. The company has seen no estimate revisions in the past 30 days, but its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Otonomy. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road. Otonomy currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. A better-ranked biotechnology stock is Nutraceutical International Corporation (NUTR), sporting a Zacks Rank #1 (Strong Buy). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report OTONOMY INC (OTIC): Free Stock Analysis Report NUTRACEUTICAL (NUTR): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View comments
Title: Fears of Parenthood Amid Climate Change Concerns
Many millennials are hesitant to have children due to the impacts of climate change and the future uncertainties they face.